Innoviz CEO discloses initial holdings
Innoviz Technologies Ltd. director and Chief Executive Officer Omer David Keilaf reported his initial ownership on Form 3.
Rhea-AI Filing Summary
Innoviz Technologies Ltd. director and Chief Executive Officer Omer David Keilaf reported his initial ownership on Form 3. He directly holds 4,228,950 ordinary shares, which include 1,143,106 shares issuable upon vesting of restricted share units granted between 2022 and 2025 on various quarterly schedules.
He also holds multiple option grants over Innoviz ordinary shares, including 1,020,444 options at an exercise price of $11.50 expiring in 2028 and additional tranches at lower exercise prices expiring through 2032, plus 40,000 public warrants at $11.50. In addition, he holds 6,256,265 performance share units that may convert into ordinary shares if share-price targets between $2.00 and $5.50 are met and service conditions are satisfied.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Keilaf Omer David
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Warrant | -- | -- | -- |
| holding | PSU | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option — 2,236,748 contracts (Direct);
Warrant — 40,000 contracts (Direct);
PSU — 6,256,265 contracts (Direct);
Ordinary Shares — 4,228,950 shares (Direct)
Footnotes (9)
- F1. Includes 1,143,106 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 15,596 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 43,956 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 74,008 RSUs granted February 27, 2024, with 14,232 vesting quarterly through 2027 and 59,776 vesting quarterly through 2028; (d) 60,590 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 82,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 750,000 RSUs granted May 26, 2025, one-fourth vesting on May 26, 2026, remainder vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
- F2. No exercise price is applicable.
- F3. Immediately exercisable.
- F4. Share options granted on August 9, 2022. Includes 81,872 vested options, and 11,696 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
- F5. Share options granted on August 1, 2023. Includes 73,260 vested options, and 43,956 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
- F6. Share options granted on August 20, 2024. Includes 54,534 vested options, and 90,890 unvested options, which shall vest in equal quarterly installments through 2028, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
- F7. Share options granted on August 5, 2025. Includes no vested options, and 175,280 unvested options, with one-fourth of the options vesting on August 5, 2026, and the remaining shall vest in equal quarterly installments through 2029, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
- F8. Public warrants (traded under the symbol INVZW) originally issued in connection with the Business Combination with Collective Growth Corporation. Each warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share. The warrants expire on April 5, 2026.
- F9. Performance share units granted on December 16, 2025. The PSUs vest based on the achievement of share price performance targets measured during any consecutive 60 trading day period between the second and fifth anniversaries of the grant date. The share price targets are: 1,251,254 PSUs at $2.00; 1,668,337 PSUs at $3.00; 1,668,337 PSUs at $4.50; and 1,668,337 PSUs at $5.50. Achieved PSUs vest quarterly over four years from the grant date (one-sixteenth per quarter), subject to the Reporting Person's continued service. Each PSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Innoviz (INVZ) CEO Omer Keilaf report on this Form 3?
He reported his initial ownership position in Innoviz. The filing lists 4,228,950 ordinary shares (including RSU-based shares), several option grants, 40,000 public warrants, and 6,256,265 performance share units, showing his total equity-based stake as a company insider.
What stock options does Innoviz (INVZ) CEO Omer Keilaf have?
He holds several option grants over Innoviz ordinary shares. These include 1,020,444 options at an exercise price of $11.50 and additional tranches at $9.92, $5.23, $4.03, $0.75, and $1.61, with expirations ranging from 2028 through 2032.
Does Innoviz (INVZ) CEO hold any public warrants?
Yes, he holds 40,000 public warrants. Each warrant entitles the holder to purchase one Innoviz ordinary share at an exercise price of $11.50 per share, and the warrants are scheduled to expire on April 5, 2026, if they are not exercised before that date.
Are the RSUs reported by Innoviz (INVZ) CEO already vested?
Only a portion of the reported RSUs are vested. The 1,143,106 RSUs include multiple grants from 2022–2025, with remaining unvested units scheduled to vest in equal quarterly installments through years such as 2028 and 2029, contingent on continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
